变量 | N = 457 |
性别 |
|
女 | 204 (44.6%) |
男 | 253 (55.4%) |
年龄(岁) |
|
≤40 | 229 (50.1%) |
>40 | 228 (49.9%) |
主要治疗结果 |
|
完全缓解 | 132 (28.9%) |
部分缓解 | 64 (14.0%) |
病情稳定 | 157 (34.4%) |
疾病进展 | 104 (22.8%) |
组织学类型 |
|
星形细胞瘤 | 169 (37.0%) |
少星形细胞瘤 | 120 (26.3%) |
少突胶质细胞瘤 | 168 (36.8%) |
ICD-O-3组织学编码 |
|
9382/3 | 121 (26.5%) |
9400/3 | 57 (12.5%) |
9401/3 | 112 (24.5%) |
9450/3 | 100 (21.9%) |
9451/3 | 67 (14.7%) |
肿瘤组织学分级 |
|
G2 | 224 (49.0%) |
G3 | 233 (51.0%) |
术后 |
|
否 | 198 (43.3%) |
是 | 259 (56.7%) |
放射治疗 |
|
否 | 177 (38.7%) |
是 | 280 (61.3%) |
癫痫发作史 |
|
否 | 163 (35.7%) |
是 | 294 (64.3%) |
头痛史 |
|
否 | 295 (64.6%) |
是 | 162 (35.4%) |
精神状态改变史 |
|
否 | 349 (76.4%) |
是 | 108 (23.6%) |
运动改变史 |
|
否 | 357 (78.1%) |
是 | 100 (21.9%) |
首次症状持续时间(天) |
|
>180 | 117 (25.6%) |
0~30 | 232 (50.8%) |
31~90 | 71 (15.5%) |
91~180 | 37 (8.1%) |
IDH1突变测试 |
|
否 | 307 (67.2%) |
是 | 150 (32.8%) |